1,529
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Novel pyrazole–pyrazoline hybrids endowed with thioamide as antimalarial agents: their synthesis and 3D-QSAR studies

, , , &
Pages 597-606 | Received 03 Jun 2014, Accepted 17 Aug 2014, Published online: 21 Oct 2014

Figures & data

Figure 1. Commercially available drugs bearing pyrazole nucleus.

Figure 1. Commercially available drugs bearing pyrazole nucleus.

Figure 2. Title compounds bearing the structural motifs.

Figure 2. Title compounds bearing the structural motifs.

Table 1. IC50 and SI values of the synthesised compounds.

Figure 3. Active alignment of the data set.

Figure 3. Active alignment of the data set.

Figure 4. Title compounds showing AMX pattern and the different rings.

Figure 4. Title compounds showing AMX pattern and the different rings.

Scheme 1. Reagents and conditions: (i) Phenyl hydrazine, GAA, methanol, reflux; (ii) DMF, POCL3; (iii) Aromatic ketone, NaOH, methanol, reflux; (iv) Thiosemicarbazide, ethanol, reflux.

Scheme 1. Reagents and conditions: (i) Phenyl hydrazine, GAA, methanol, reflux; (ii) DMF, POCL3; (iii) Aromatic ketone, NaOH, methanol, reflux; (iv) Thiosemicarbazide, ethanol, reflux.

Table 2. Statistical parameters of the best model.

Figure 5. Fitness plot of the model.

Figure 5. Fitness plot of the model.

Figure 6. Electron withdrawing, Hydrogen bond donor and hydrophobic characteristics of the hypothesis ADHRR.9.

Figure 6. Electron withdrawing, Hydrogen bond donor and hydrophobic characteristics of the hypothesis ADHRR.9.
Supplemental material

Supplemental Material.pdf

Download PDF (24.7 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.